Skip to main content

$ALGN

INSTITUTIONAL QUANT REPORT

SHARE

Constitution Metrics (S-GRADE)

ROE
10.2%
S&P 500 Alpha: 0.7x
ROIC
19.1%
Cash Holdings
$0.0

AI 전문 투자 리포트

핵심 요약

🔥 [AI Catalyst] The 100x return secret created by focusing on ROIC Align Technology (ALGN) is a leading player in the dental technology industry with impressive returns on investment. Its strong ROIC and low PEG ratio suggest significant growth potential at a fair price. With ample cash reserves, ALGN is well-positioned to capitalize on future opportunities, making it an attractive option for savvy investors.

Bull Case (상승 모멘텀)

  • 1. High ROIC: With a 19.08% return on invested capital, ALGN demonstrates efficient capital utilization, paving the way for robust profitability. 2. Attractive Valuation: A PEG ratio of 0.61 indicates that the stock is undervalued relative to its growth potential, suggesting that savvy investors can buy in at a bargain. 3. Strong Financial Position: With over $1.1 billion in net cash, ALGN is well-equipped to invest in innovation and weather any economic downturns.

Bear Case (주의/리스크 요인)

  • 1. Stagnant Growth: The 5-year compound annual growth rate is currently at 0.00%, indicating that ALGN may struggle to generate significant revenue growth in the near future. 2. Value Trap Risk: Despite high ROE and ROIC, the absence of positive free cash flow could signal a potential value trap, where the stock is overvalued relative to its true cash-generating capabilities. 3. Market Volatility: As a tech-driven company in the healthcare sector, ALGN may be susceptible to regulatory changes and market fluctuations that could impact its performance.
마지막 분석: 10/4/2026

Top Quant Candidates

UNLOCK INSTITUTIONAL DASHBOARD

Access real-time 100-bagger detection algorithms and unmask the hidden metrics driving $ALGN's alpha.

Upgrade Now
System Status
LATENCY: 14ms

DISCLAIMER:This data is filtered by advisor Hey James' 100-Bagger Elite Alpha Engine (ROE > 25%, ROIC > 20%, Net Cash Position). It is for informational purposes only and not investment advice. Final investment decisions must be made at your own discretion and responsibility.

© 2024 QUANT LABS INC. ALL RIGHTS RESERVED.
[S-GRADE] ALGN Institutional Analysis | ROE 10.2%